Abdi İbrahim Opens Its Biotechnological Drug Production Facility AbdiBio
Abdi İbrahim opened AbdiBio, completed with an investment of 400 million Turkish lira, and laid the foundations of new sterile injectable and oncology production facilities worth 600 million lira. Built on 13,000 square metres of indoor space, AbdiBio is Türkiye’s largest biotechnological drug production facility.
This post is an English summary. The full text is available in Turkish: read the original.